Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
RESMED INC
Report date May 04, 2026 · Filed May 04, 2026
Section 16 reporting ended · disclosed 2026-05-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| ResMed Common StockSEC Table I · non-derivative | Direct | 83,495 |
Reported balance
Holding disclosure · report date 2026-05-04 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 83,495 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 18, 2022 Filed Aug 22, 2022 19:08 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 3,847 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-021423 · form4.xml · nonDerivative · entry 1 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,273 F1 · kind: Represents performance-based restricted stock units granted on November 18, 2021. The shares were earned on August 18, 2022, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 16:11 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 2,500 | $0.00 Strike: $57.76 | $0.00 |
DisclosureSEC source: 0001127602-22-020860 · form4.xml · derivative · entry 3 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Common Stock · 2,500 shares Expires 2023-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 16:11 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 2,500 | $240.66 | $601,650.00 |
DisclosureSEC source: 0001127602-22-020860 · form4.xml · nonDerivative · entry 2 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,426 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 16:11 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 2,500 | $57.76 | $144,400.00 |
DisclosureSEC source: 0001127602-22-020860 · form4.xml · nonDerivative · entry 1 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| July 22, 2022 Filed Jul 26, 2022 15:59 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 2,500 | $0.00 Strike: $57.76 | $0.00 |
DisclosureSEC source: 0001127602-22-019773 · form4.xml · derivative · entry 7 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: ResMed Common Stock · 2,500 shares Expires 2023-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| July 22, 2022 Filed Jul 26, 2022 15:59 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 2,500 | $0.00 Strike: $57.76 | $0.00 |
DisclosureSEC source: 0001127602-22-019773 · form4.xml · derivative · entry 6 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: ResMed Common Stock · 2,500 shares Expires 2023-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| July 22, 2022 Filed Jul 26, 2022 15:59 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 2,500 | $0.00 Strike: $57.76 | $0.00 |
DisclosureSEC source: 0001127602-22-019773 · form4.xml · derivative · entry 5 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: ResMed Common Stock · 2,500 shares Expires 2023-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| July 22, 2022 Filed Jul 26, 2022 15:59 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 7,500 | $235.00 | $1,762,500.00 |
DisclosureSEC source: 0001127602-22-019773 · form4.xml · nonDerivative · entry 4 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,426 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · balance_after: Includes 71.359 shares of ResMed stock purchased on April 29, 2022, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| July 22, 2022 Filed Jul 26, 2022 15:59 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 2,500 | $57.76 | $144,400.00 |
DisclosureSEC source: 0001127602-22-019773 · form4.xml · nonDerivative · entry 3 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| July 22, 2022 Filed Jul 26, 2022 15:59 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 2,500 | $57.76 | $144,400.00 |
DisclosureSEC source: 0001127602-22-019773 · form4.xml · nonDerivative · entry 2 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| July 22, 2022 Filed Jul 26, 2022 15:59 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 2,500 | $57.76 | $144,400.00 |
DisclosureSEC source: 0001127602-22-019773 · form4.xml · nonDerivative · entry 1 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| April 11, 2022 Filed Apr 12, 2022 21:54 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 2,500 | $0.00 Strike: $57.76 | $0.00 |
DisclosureSEC source: 0001127602-22-011914 · form4.xml · derivative · entry 3 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: ResMed Common Stock · 2,500 shares Expires 2023-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| April 11, 2022 Filed Apr 12, 2022 21:54 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 2,500 | $247.00 | $617,500.00 |
DisclosureSEC source: 0001127602-22-011914 · form4.xml · nonDerivative · entry 2 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,354 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| April 11, 2022 Filed Apr 12, 2022 21:54 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 2,500 | $57.76 | $144,400.00 |
DisclosureSEC source: 0001127602-22-011914 · form4.xml · nonDerivative · entry 1 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 16:14 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 2,500 | $0.00 Strike: $57.76 | $0.00 |
DisclosureSEC source: 0001127602-22-009063 · form4.xml · derivative · entry 3 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: ResMed Common Stock · 2,500 shares Expires 2023-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 16:14 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 2,500 | $241.29 | $603,225.00 |
DisclosureSEC source: 0001127602-22-009063 · form4.xml · nonDerivative · entry 2 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,354 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 16:14 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 2,500 | $57.76 | $144,400.00 |
DisclosureSEC source: 0001127602-22-009063 · form4.xml · nonDerivative · entry 1 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 17:59 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 2,500 | $0.00 Strike: $57.76 | $0.00 |
DisclosureSEC source: 0001127602-22-004725 · form4.xml · derivative · entry 3 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: ResMed Common Stock · 2,500 shares Expires 2023-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 17:59 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 2,500 | $241.86 | $604,650.00 |
DisclosureSEC source: 0001127602-22-004725 · form4.xml · nonDerivative · entry 2 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,354 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 17:59 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 2,500 | $57.76 | $144,400.00 |
DisclosureSEC source: 0001127602-22-004725 · form4.xml · nonDerivative · entry 1 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| January 10, 2022 Filed Jan 11, 2022 22:18 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 2,500 | $0.00 Strike: $57.76 | $0.00 |
DisclosureSEC source: 0001127602-22-001337 · form4.xml · derivative · entry 3 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: ResMed Common Stock · 2,500 shares Expires 2023-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| January 10, 2022 Filed Jan 11, 2022 22:18 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 2,500 | $235.00 | $587,500.00 |
DisclosureSEC source: 0001127602-22-001337 · form4.xml · nonDerivative · entry 2 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,354 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| January 10, 2022 Filed Jan 11, 2022 22:18 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 2,500 | $57.76 | $144,400.00 |
DisclosureSEC source: 0001127602-22-001337 · form4.xml · nonDerivative · entry 1 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 20:48 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 2,500 | $0.00 Strike: $57.76 | $0.00 |
DisclosureSEC source: 0001127602-21-030901 · form4.xml · derivative · entry 3 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: ResMed Common Stock · 2,500 shares Expires 2023-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 20:48 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 2,500 | $264.92 | $662,300.00 |
DisclosureSEC source: 0001127602-21-030901 · form4.xml · nonDerivative · entry 2 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,354 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 20:48 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 2,500 | $57.76 | $144,400.00 |
DisclosureSEC source: 0001127602-21-030901 · form4.xml · nonDerivative · entry 1 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| November 18, 2021 Filed Nov 18, 2021 22:41 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,161 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-029582 · form4.xml · nonDerivative · entry 2 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,354 F2 · kind: Represents performance-based restricted stock units granted on November 19, 2020. The shares were earned on November 18, 2021, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date. Read SEC document |
| November 16, 2021 Filed Nov 18, 2021 22:41 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 20,360 | $254.81 | $5,187,931.60 |
DisclosureSEC source: 0001127602-21-029582 · form4.xml · nonDerivative · entry 1 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,193 F1 · kind: Represents performance-based restricted stock units granted on November 14, 2018. The shares were earned on November 16, 2021, when the compensation committee certified that the performance metrics were met. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 18:17 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 2,500 | $0.00 Strike: $57.76 | $0.00 |
DisclosureSEC source: 0001127602-21-028929 · form4.xml · derivative · entry 3 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: ResMed Common Stock · 2,500 shares Expires 2023-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F3 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 18:17 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 2,500 | $260.58 | $651,450.00 |
DisclosureSEC source: 0001127602-21-028929 · form4.xml · nonDerivative · entry 2 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,833 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · balance_after: Includes 46.9876 shares of ResMed stock purchased on October 29, 2021, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 18:17 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 2,500 | $57.76 | $144,400.00 |
DisclosureSEC source: 0001127602-21-028929 · form4.xml · nonDerivative · entry 1 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| October 11, 2021 Filed Oct 12, 2021 22:57 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 2,500 | $0.00 Strike: $57.76 | $0.00 |
DisclosureSEC source: 0001127602-21-026987 · form4.xml · derivative · entry 3 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: ResMed Common Stock · 2,500 shares Expires 2023-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| October 11, 2021 Filed Oct 12, 2021 22:57 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 5,000 | $253.37 | $1,266,850.00 |
DisclosureSEC source: 0001127602-21-026987 · form4.xml · nonDerivative · entry 2 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,786 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| October 11, 2021 Filed Oct 12, 2021 22:57 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 2,500 | $57.76 | $144,400.00 |
DisclosureSEC source: 0001127602-21-026987 · form4.xml · nonDerivative · entry 1 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,786 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| September 10, 2021 Filed Sep 13, 2021 20:17 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 2,500 | $0.00 Strike: $57.76 | $0.00 |
DisclosureSEC source: 0001127602-21-025210 · form4.xml · derivative · entry 3 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 Underlying: ResMed Common Stock · 2,500 shares Expires 2023-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| September 10, 2021 Filed Sep 13, 2021 20:17 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 5,000 | $297.33 | $1,486,650.00 |
DisclosureSEC source: 0001127602-21-025210 · form4.xml · nonDerivative · entry 2 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,286 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| September 10, 2021 Filed Sep 13, 2021 20:17 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 2,500 | $57.76 | $144,400.00 |
DisclosureSEC source: 0001127602-21-025210 · form4.xml · nonDerivative · entry 1 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| August 20, 2021 Filed Aug 23, 2021 23:05 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 5,543 | $0.00 Strike: $57.76 | $0.00 |
DisclosureSEC source: 0001127602-21-024177 · form4.xml · derivative · entry 5 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: ResMed Common Stock · 5,543 shares Expires 2023-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| August 20, 2021 Filed Aug 23, 2021 23:05 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 5,193 | $0.00 Strike: $57.76 | $0.00 |
DisclosureSEC source: 0001127602-21-024177 · form4.xml · derivative · entry 4 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,543 Underlying: ResMed Common Stock · 5,193 shares Expires 2023-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| August 20, 2021 Filed Aug 23, 2021 23:05 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 10,736 | $281.73 | $3,024,653.28 |
DisclosureSEC source: 0001127602-21-024177 · form4.xml · nonDerivative · entry 3 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,786 Read SEC document |
| August 20, 2021 Filed Aug 23, 2021 23:05 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 5,543 | $57.76 | $320,163.68 |
DisclosureSEC source: 0001127602-21-024177 · form4.xml · nonDerivative · entry 2 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,522 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| August 20, 2021 Filed Aug 23, 2021 23:05 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 5,193 | $57.76 | $299,947.68 |
DisclosureSEC source: 0001127602-21-024177 · form4.xml · nonDerivative · entry 1 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| August 19, 2021 Filed Aug 20, 2021 16:05 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 4,784 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-024094 · form4.xml · nonDerivative · entry 1 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,786 F1 · kind: Represents performance-based restricted stock units granted on November 19, 2020. The shares were earned on August 19, 2021, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 22:21 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 2,500 | $278.05 | $695,125.00 |
DisclosureSEC source: 0001127602-21-023535 · form4.xml · nonDerivative · entry 1 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,002 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| July 12, 2021 Filed Jul 13, 2021 22:10 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 2,500 | $248.46 | $621,150.00 |
DisclosureSEC source: 0001127602-21-021895 · form4.xml · nonDerivative · entry 1 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,502 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 13:53 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 2,500 | $212.84 | $532,100.00 |
DisclosureSEC source: 0001127602-21-019756 · form4.xml · nonDerivative · entry 1 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,002 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| May 10, 2021 Filed May 11, 2021 23:07 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 2,500 | $196.00 | $490,000.00 |
DisclosureSEC source: 0001127602-21-016280 · form4.xml · nonDerivative · entry 1 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,502 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · balance_after: Includes 80.54 shares of ResMed stock purchased on April 30, 2021, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| April 12, 2021 Filed Apr 13, 2021 21:22 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 2,500 | $198.47 | $496,175.00 |
DisclosureSEC source: 0001127602-21-013698 · form4.xml · nonDerivative · entry 1 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,922 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 22:43 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 2,500 | $185.00 | $462,500.00 |
DisclosureSEC source: 0001127602-21-010277 · form4.xml · nonDerivative · entry 1 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,422 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 21:45 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 2,500 | $201.37 | $503,425.00 |
DisclosureSEC source: 0001127602-21-005251 · form4.xml · nonDerivative · entry 1 Sandercock Brett · CIK 0001346064 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,922 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.